Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. 2011

Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
Instituto de Salud Pública de Navarra, Pamplona, Spain. jcastilc@navarra.es

We defined a population-based cohort (596,755 subjects) in Navarre, Spain, using electronic records from physicians, to evaluate the effectiveness of the monovalent A(H1N1)2009 vaccine in preventing influenza in the 2009-2010 pandemic season. During the 9-week period of vaccine availability and circulation of the A(H1N1)2009 virus, 4608 cases of medically attended influenza-like illness (MA-ILI) were registered (46 per 1000 person-years). After adjustment for sociodemographic covariables, outpatient visits and major chronic conditions, vaccination was associated with a 32% (95% CI: 8-50%) reduction in the overall incidence of MA-ILI. In a test negative case-control analysis nested in the cohort, swabs from 633 patients were included, and 123 were confirmed for A(H1N1)2009 influenza. No confirmed case had received A(H1N1)2009 vaccine versus 9.6% of controls (p<0.001). The vaccine effectiveness in preventing laboratory-confirmed influenza was 89% (95% CI: 36-100%) after adjusting for age, health care setting, major chronic conditions and period. Pandemic vaccine was effective in preventing MA-ILI and confirmed cases of influenza A(H1N1)2009 in the 2009-2010 season.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
February 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
February 2011, Vaccine,
Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
September 2013, Vaccine,
Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
January 2015, Human vaccines & immunotherapeutics,
Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
November 2011, BMC public health,
Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
December 2009, The New England journal of medicine,
Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
November 2009, Vaccine,
Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
December 2009, The New England journal of medicine,
Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
May 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
Jesús Castilla, and Julio Morán, and Víctor Martínez-Artola, and Mirian Fernández-Alonso, and Marcela Guevara, and Manuel García Cenoz, and Gabriel Reina, and Nerea Alvarez, and Maite Arriazu, and Fernando Elía, and Esther Salcedo, and Aurelio Barricarte, and
September 2010, Human vaccines,
Copied contents to your clipboard!